These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2861933)

  • 21. [Psychosomatic effects of intramuscular premedication wtih flunitrazepam, innovar and a placebo in combination with atropine (author's transl)].
    Tolksdorf W; Berlin J; Bethke U; Nieder G
    Anasth Intensivther Notfallmed; 1981 Feb; 16(1):1-4. PubMed ID: 6112932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term benzodiazepine therapy: benefits and risks.
    Rickels K; Case GW; Winokur A; Swenson C
    Psychopharmacol Bull; 1984; 20(4):608-15. PubMed ID: 6149596
    [No Abstract]   [Full Text] [Related]  

  • 23. Benzodiazepine dependence, withdrawal severity, and clinical outcome: effects of personality.
    Rickels K; Schweizer E; Case GW; Garcia-Espana F
    Psychopharmacol Bull; 1988; 24(3):415-20. PubMed ID: 2908677
    [No Abstract]   [Full Text] [Related]  

  • 24. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?
    Pellow S
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):557-65. PubMed ID: 2877126
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of chronic drug-induced neutropenia.
    Khan AY; Golewale MH; Kahn DA
    J Psychiatr Pract; 2008 Jul; 14(4):246-50. PubMed ID: 18664895
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical dose dependence of anti-anxiety agents].
    Murasaki M
    Seishin Shinkeigaku Zasshi; 1996; 98(9):612-21. PubMed ID: 9064692
    [No Abstract]   [Full Text] [Related]  

  • 27. Panic disorder: guidelines to safe use of benzodiazepines.
    Garvey MJ
    Geriatrics; 1993 Jul; 48(7):49-53, 56-8. PubMed ID: 8100794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of anxiety in the elderly: the balance between therapeutic and adverse effects.
    Shader RI; Greenblatt DJ
    J Clin Psychiatry; 1982 Sep; 43(9 Pt 2):8-18. PubMed ID: 6127336
    [No Abstract]   [Full Text] [Related]  

  • 29. [Visual hallucinations and carpipramine].
    Clavelou P; Fialip J; Monange P; Lavarenne J; Dordain G; Tournilhac M
    Therapie; 1988 May; 43(3):239-40. PubMed ID: 2901794
    [No Abstract]   [Full Text] [Related]  

  • 30. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract]   [Full Text] [Related]  

  • 31. [Strong withdrawal syndrome with benzodiazpines (six cases) (author's transl)].
    Le Bellec M; Bismuth C; Lagier G; Dally S
    Therapie; 1980; 35(1):113-8. PubMed ID: 6106299
    [No Abstract]   [Full Text] [Related]  

  • 32. [Manic switch induced by clorazepate (5 cases)].
    Bourgeois M; Goumilloux R; Peyre F; Assens F; Degeilh B
    Ann Med Psychol (Paris); 1987 Oct; 145(10):855-60. PubMed ID: 2894792
    [No Abstract]   [Full Text] [Related]  

  • 33. [Skin disorders caused by the use of camazepam (Albego)].
    Stricker BH
    Ned Tijdschr Geneeskd; 1984 May; 128(18):870-2. PubMed ID: 6145108
    [No Abstract]   [Full Text] [Related]  

  • 34. Peripheral injection of dexamethasone modulates anxiety related behaviors in mice: an interaction with opioidergic neurons.
    Vafaei AA; Rashidy-Pour A; Taherian AA
    Pak J Pharm Sci; 2008 Jul; 21(3):285-9. PubMed ID: 18614426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of antianxiety and tranquilizing agent dependence in Japan].
    Fukui S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Oct; 19(4):209-13. PubMed ID: 10637830
    [No Abstract]   [Full Text] [Related]  

  • 36. Recurrent paroxetine-induced hyponatremia.
    Malik AR; Wolf PK; Ravasia S
    Can J Psychiatry; 2004 Nov; 49(11):785. PubMed ID: 15633859
    [No Abstract]   [Full Text] [Related]  

  • 37. Pilot testing of telephone conferencing to help reduce tranquillizer dependence.
    Mulleady G
    Addiction; 2001 Nov; 96(11):1679-80. PubMed ID: 11791511
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot open-label study on U-31,889 in anxious in-patients.
    Fabre LF; Harris RT
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1010-3. PubMed ID: 4154181
    [No Abstract]   [Full Text] [Related]  

  • 40. [Withdrawal phenomena in stepwise withdrawal of benzodiazepines].
    Soyka M; Steinberg R; Vollmer M
    Nervenarzt; 1988 Dec; 59(12):744-8. PubMed ID: 2905772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.